Nuwellis (NASDAQ:NUWE – Get Free Report) and Pixie Dust Technologies (NASDAQ:PXDT – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations.
Profitability
This table compares Nuwellis and Pixie Dust Technologies’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Nuwellis | -232.24% | -1,716.60% | -245.90% |
Pixie Dust Technologies | N/A | N/A | N/A |
Institutional and Insider Ownership
3.1% of Nuwellis shares are owned by institutional investors. Comparatively, 0.4% of Pixie Dust Technologies shares are owned by institutional investors. 2.6% of Nuwellis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Analyst Recommendations
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Nuwellis | 0 | 1 | 1 | 1 | 3.00 |
Pixie Dust Technologies | 0 | 0 | 1 | 0 | 3.00 |
Nuwellis currently has a consensus target price of $17.00, indicating a potential upside of 1,417.86%. Pixie Dust Technologies has a consensus target price of $5.21, indicating a potential upside of 249.69%. Given Nuwellis’ higher probable upside, analysts plainly believe Nuwellis is more favorable than Pixie Dust Technologies.
Earnings and Valuation
This table compares Nuwellis and Pixie Dust Technologies”s revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Nuwellis | $8.86 million | 0.24 | -$20.21 million | ($290.21) | 0.00 |
Pixie Dust Technologies | $6.30 million | 3.52 | -$12.53 million | N/A | N/A |
Pixie Dust Technologies has lower revenue, but higher earnings than Nuwellis.
About Nuwellis
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama. Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
About Pixie Dust Technologies
Pixie Dust Technologies, Inc., a technology company, focuses on personal care and diversity, and workspace and digital transformation businesses primarily in Japan. It offers SonoRepro, an ultrasonic non-contact vibrotactile stimulation scalp care device; VUEVO, a series of directional voice arrival detection devices for individuals with deaf and hard-of-hearing; and kikippa, an acoustic stimulation device functioning as a desk-top speaker. The company also provides iwasemi, a sound-absorbing or sound-proofing material for architectural and interior design firms; hackke, a location positioning technology; KOTOWARI, a technology offering spatial analysis data; and magickiri, a planning services and monitoring service, which monitors human behavior and analyzes the customer's environment on the customer's behalf. In addition, it operates Pixie Nest, a membership forum, which hosts meetings and distributes information to facilitate solving social issues. The company was incorporated in 2017 and is headquartered in Tokyo, Japan.
Receive News & Ratings for Nuwellis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuwellis and related companies with MarketBeat.com's FREE daily email newsletter.